These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22581259)

  • 1. Neuroprotection in diabetic retinopathy.
    Hernández C; Simó R
    Curr Diab Rep; 2012 Aug; 12(4):329-37. PubMed ID: 22581259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives.
    Simó R; Hernández C;
    Trends Endocrinol Metab; 2014 Jan; 25(1):23-33. PubMed ID: 24183659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin replacement: a new strategy for treating diabetic retinopathy.
    Hernández C; Simó R;
    Curr Med Chem; 2013; 20(26):3251-7. PubMed ID: 23745546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications.
    Simó R; Hernández C;
    Br J Ophthalmol; 2012 Oct; 96(10):1285-90. PubMed ID: 22887976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma angiogenesis and oxidative stress markers in patients with diabetic retinopathy.
    Gaonkar B; Prabhu K; Rao P; Kamat A; Rao Addoor K; Varma M
    Biomarkers; 2020 Jul; 25(5):397-401. PubMed ID: 32529845
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroprotection as a Therapeutic Target for Diabetic Retinopathy.
    Hernández C; Dal Monte M; Simó R; Casini G
    J Diabetes Res; 2016; 2016():9508541. PubMed ID: 27123463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodegeneration: An early event of diabetic retinopathy.
    Villarroel M; Ciudin A; Hernández C; Simó R
    World J Diabetes; 2010 May; 1(2):57-64. PubMed ID: 21537428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection for diabetic retinopathy.
    Imai H; Singh RSJ; Fort PE; Gardner TW
    Dev Ophthalmol; 2009; 44():56-68. PubMed ID: 19494653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far.
    Whitmire W; Al-Gayyar MM; Abdelsaid M; Yousufzai BK; El-Remessy AB
    Mol Vis; 2011 Jan; 17():300-8. PubMed ID: 21293735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurovascular cross talk in diabetic retinopathy: Pathophysiological roles and therapeutic implications.
    Moran EP; Wang Z; Chen J; Sapieha P; Smith LE; Ma JX
    Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H738-49. PubMed ID: 27473938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of vascular endothelial growth factor and pigment epithelium-derived factor before and after intravitreal injection of bevacizumab.
    Matsuyama K; Ogata N; Matsuoka M; Wada M; Takahashi K; Nishimura T
    Br J Ophthalmol; 2010 Sep; 94(9):1215-8. PubMed ID: 20538658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoprotective effect of agmatine in streptozotocin-induced diabetic rat model: avenues for vascular and neuronal protection : Agmatine in diabetic retinopathy.
    Abo El Gheit RE; Soliman NA; Badawi GA; Madi NM; El-Saka MH; Badr SM; Emam MN
    J Physiol Biochem; 2021 May; 77(2):305-320. PubMed ID: 33635523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of diabetic retinopathy with intravitreal Ranibizumab.
    Kernt M; Cserhati S; Seidensticker F; Liegl R; Kampik A; Neubauer A; Ulbig MW; Reznicek L
    Diabetes Res Clin Pract; 2013 Apr; 100(1):e11-3. PubMed ID: 23391744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregabalin affords retinal neuroprotection in diabetic rats: Suppression of retinal glutamate, microglia cell expression and apoptotic cell death.
    Ali SA; Zaitone SA; Dessouki AA; Ali AA
    Exp Eye Res; 2019 Jul; 184():78-90. PubMed ID: 31002823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal Neurodegeneration as an Early Manifestation of Diabetic Eye Disease and Potential Neuroprotective Therapies.
    Zafar S; Sachdeva M; Frankfort BJ; Channa R
    Curr Diab Rep; 2019 Feb; 19(4):17. PubMed ID: 30806815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium Dobesilate Prevents Neurodegeneration and Vascular Leakage in Experimental Diabetes.
    Solà-Adell C; Bogdanov P; Hernández C; Sampedro J; Valeri M; Garcia-Ramirez M; Pasquali C; Simó R
    Curr Eye Res; 2017 Sep; 42(9):1273-1286. PubMed ID: 28574750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma concentration of pigment epithelium-derived factor in patients with diabetic retinopathy.
    Ogata N; Matsuoka M; Matsuyama K; Shima C; Tajika A; Nishiyama T; Wada M; Jo N; Higuchi A; Minamino K; Matsunaga H; Takeda T; Matsumura M
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1176-9. PubMed ID: 17213275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth Factors in the Pathogenesis of Retinal Neurodegeneration in Diabetes Mellitus.
    Iwona BS
    Curr Neuropharmacol; 2016; 14(8):792-804. PubMed ID: 27528260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodegeneration in diabetic retinopathy: does it really matter?
    Simó R; Stitt AW; Gardner TW
    Diabetologia; 2018 Sep; 61(9):1902-1912. PubMed ID: 30030554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegeneration and Neuroinflammation in Diabetic Retinopathy: Potential Approaches to Delay Neuronal Loss.
    Kadłubowska J; Malaguarnera L; Wąż P; Zorena K
    Curr Neuropharmacol; 2016; 14(8):831-839. PubMed ID: 27306035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.